Getting ahead of Brain Tumours with Ruby Hall Clinic Wanowrie

Every year on 8th June, the world unites to raise awareness about brain tumours on World Brain Tumour Day. This day, dedicated to enlightening the public about brain health and prevention, serves as a crucial reminder of the impact brain tumours have on individuals and their families. The theme for this year, “Brain Health and Prevention,” underscores the importance of early detection, research, and comprehensive care.

Brain tumours are abnormal growths of cells within the brain, which can be classified into two main categories — primary and secondary. Primary brain tumours originate in the brain and include types such as gliomas, meningiomas, and schwannomas. Gliomas, the most common type, arise from glial cells, while meningiomas develop from the meninges, the protective layers surrounding the brain. Schwannomas affect the nerve sheath cells. Secondary, or metastatic, brain tumours spread to the brain from other parts of the body and are often linked with cancers like lung, breast, and melanoma.

Not all brain tumours are cancerous. Benign brain tumours, though non-cancerous, can still cause significant health issues due to their location and size. Malignant brain tumours are cancerous and more aggressive, requiring prompt and intensive treatment.

“Recognising the signs and symptoms of brain tumours is crucial for early diagnosis. Common symptoms include persistent headaches, often worse in the morning, seizures, vision problems, and changes in personality or behaviour,” says Dr. Nilesh Palasdeokar, Consultant Neurologist, Ruby Hall Clinic Wanowrie. “Early detection can significantly improve clinical outcomes. Patients should be vigilant and seek medical attention if they experience persistent neurological symptoms,” he adds.

Treatment options for brain tumours vary depending on the type, location, and grade of the tumour. Dr. Richa Singh, Consultant Neurologist, Ruby Hall Clinic Wanowrie explains, “Surgery is often the first line of treatment, aiming to remove as much of the tumour as possible. In cases where the tumour is inaccessible or surgery poses significant risks, radiotherapy and chemotherapy are employed. Advanced treatments, such as targeted therapy and immunotherapy, are showing promising results, particularly for malignant tumours.The advent of personalised medicine has revolutionised our approach to treating brain tumours. Tailoring treatment to the genetic profile of the tumour can enhance efficacy and minimise side effects.”

Clinical outcomes for brain tumour patients have improved with advances in medical technology and treatment protocols. However, prognosis varies widely based on the tumour’s type, size, location, and the patient’s overall health. Benign tumours, when treated promptly, often have favourable outcomes, while malignant tumours can be more challenging to manage. Continuous research and clinical trials are essential for developing new treatments and improving survival rates.

On World Brain Tumour Day, it is imperative to highlight the importance of brain health and prevention. Public education campaigns and community engagement play a vital role in early detection and reducing the incidence of brain tumours. Regular health check-ups and awareness of family medical history can aid in identifying risks early on. As we observe World Brain Tumour Day 2024, let us pledge to prioritise brain health and support those affected by brain tumours.